US OptionsDetailed Quotes
SAM250117C460000
- 0.00
- 0.000.00%
15min DelayClose Jan 24 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest460.00Strike Price0.00Turnover0.00%IV85.17%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier-7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Boston Beer Stock Discussion
Sign in to post a comment
Morning Movers
Gapping up
$GE Aerospace (GE.US)$ — Shares rose over 7% after the company reported fourth-quarter results that exceeded analyst estimates.
$Guidewire Software (GWRE.US)$ — Shares rose over 5% in pre-market trading after Goldman Sachs initiated coverage with a buy rating, highlighting the company as a leader in cloud modernization for the property and casualty insurance sector.
$Knight-Swift Transportation (KNX.US)$ – Shares rose 5%...
Gapping up
$GE Aerospace (GE.US)$ — Shares rose over 7% after the company reported fourth-quarter results that exceeded analyst estimates.
$Guidewire Software (GWRE.US)$ — Shares rose over 5% in pre-market trading after Goldman Sachs initiated coverage with a buy rating, highlighting the company as a leader in cloud modernization for the property and casualty insurance sector.
$Knight-Swift Transportation (KNX.US)$ – Shares rose 5%...
27
2
8
$Boston Beer (SAM.US)$ Cheap. Fall is their best time with their seasonal products. Could be larger news in the pipeline before then. I am buying and holding for a bit.
$ImmunoPrecise Antibodies (IPA.US)$ $Boston Beer (SAM.US)$ $Anheuser-Busch Inbev (BUD.US)$ should be offended.. KEGS was a good ticker name but they fuct that up
$Boston Beer (SAM.US)$ 1350 to under 300.. didn't they buy out more stuff, shouldn't they have big revenue.. if CVNA can 300 to 3 to 130.. this can 300 to 3000, 9 mill float too.. but 283 a share, who is gonna pump it?
$Boston Beer (SAM.US)$ good thing about this one is the Rich People buy it so while i can't afford it and need to downgrade my Budweiser to Busch.. this should make a recovery towards 600
4
2
$DexCom (DXCM.US)$ — Shares of the medical device company plunged more than 35%. Dexcom’s fiscal full-year revenue guidance of $4 billion to $4.05 billion marked a reduction from the outlook it shared earlier in the year. Revenue in the second quarter missed analysts’ expectations, coming in at $1 billion versus consensus estimates of $1.04 billion, per LSEG. Insulet shares slipped 9.1% in sympathy.
$Boston Beer (SAM.US)$ –...
$Boston Beer (SAM.US)$ –...
1
Boston Beer Company's revenue growth is expected to slow down substantially, underperforming the wider industry. Despite this, the consensus price target remains unchanged, suggesting that the downgrades are not expected to have a long-term impact on the company's valuation.
2
No comment yet
Buy n Die Together❤ :
RDK79 : Syueee, thanks for ‘liking’ this post, otherwise i likely would not have seen it. Good info this morning.![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")